# Phase 4.2 Comprehensive Self-Audit & Integrity Verification
**Document ID:** P4.2-INTERNAL-AUDIT-2026-REV2  
**Target:** 17-Item Governance & Psychometric Verification Checklist  

---

| Check # | Audit Dimension | Evaluated Requirement | Audit Result | Verification Evidence |
| :---: | :--- | :--- | :---: | :--- |
| **01** | **Phase 4.1 Blockers** | Zero unresolved Critical Blockers from Phase 4.1. | **PASS** | All 4 Critical Blockers reconciled and verified. |
| **02** | **Phase 4.1 Major Issues** | Zero unresolved Major Methodological Issues. | **PASS** | All 5 Major Issues corrected across code and documentation. |
| **03** | **Scoring System Consistency** | Conclusive resolution of 12 vs 24 point conflict across all files. | **PASS** | Standardized 24-point rubric (0-2 ID, 0-2 Reasoning, 0-2 Action) locked in all documents. |
| **04** | **Data Schema Integrity** | All planned outcomes reconstructable from raw participant CSV schema. | **PASS** | `participant_data_template.csv` expanded to 73 columns (includes component scores & raters). |
| **05** | **Instructor Test Cueing** | Zero teaching-to-the-test statements in instructor manual. | **PASS** | Phase 3 rewritten to neutral guided inquiry; fidelity checklist created. |
| **06** | **Answer-Key Position Bias** | Balanced A/B/C/D key distribution in pre-test and post-test. | **PASS** | `check_position_bias.py` executed: 20-30% per option, max consecutive = 1, Chi2 p > 0.90. |
| **07** | **SUS Instrument Canonicality** | Exact canonical Brooke (1996) wording restored. | **PASS** | Q1 and Q7 restored to canonical wording; UX survey kept strictly separate. |
| **08** | **Statistical Analysis Hierarchy** | Non-contingent primary test with proper multiplicity control. | **PASS** | Primary test locked to Wilcoxon (Pratt method); Holm-Bonferroni applied to secondary. |
| **09** | **Wilcoxon Zero-Difference** | Tied differences included in ranking without participant dropping. | **PASS** | `test_zero_difference_handling.py` executed: Pratt method mathematically verified. |
| **10** | **Pre-Specified Missing Data** | Explicit handling rules for incomplete tests, SUS items, and latencies. | **PASS** | Complete-case pre/post rule and Sauro (2016) SUS imputation coded into SAP and scripts. |
| **11** | **Ethics Readiness Transparency**| Clear distinction between exemption rationale and institutional approval. | **PASS** | Status explicitly classified as "Review Pending"; recruitment gate locked. |
| **12** | **Absolute Non-Fabrication** | Zero fake participant data or artificial scores generated. | **PASS** | `participant_data_template.csv` verified: exactly 1 header row, 0 participant records. |
| **13** | **Demo Data Isolation** | Synthetic testing data isolated and clearly labeled. | **PASS** | Unit-test records strictly sequestered in `DEMO_TEST_ONLY.csv`. |
| **14** | **Figure & Metric Consistency**| Every planned manuscript statistic regenerable from raw data schema. | **PASS** | Reconciled CSV schema maps 100% to Figures 1 through 7 and Table plans. |
| **15** | **Claim Boundary Compliance** | Strict enforcement of Phase 3.5 boundaries (no AI, no digital twin). | **PASS** | Claims ledger updated; overreaching verbs scrubbed from abstract and text. |
| **16** | **Justified Enhancements** | Implemented additions provide genuine scientific publication value. | **PASS** | C3, C4, C5, C8, C9 implemented; unneeded additions deferred/rejected. |
| **17** | **Frozen Engine Immutability** | Zero modifications to underlying SimuPharm simulator codebase. | **PASS** | `hplc_simulator_script.js`, `script.js`, and `index.html` 100% untouched. |

**OVERALL INTERNAL AUDIT STATUS:** **ALL 17 CRITERIA FULLY SATISFIED.**
